Development of Early Diagnostic Techniques and Setup of Local Therapeutic Guidelines and Standards (Hmodialysis)
End-stage renal disease (ESRD) is a healthy, social and economic threat worldwide. In the past ten years, the incidence and prevalence of ESRD patients have tremendously increased, ranking at the top in the world. The reasons for such high incidence and prevalence are multifactor. Early diagnosis and closed monitor of the patients with chronic kidney disease (CKD) may be beneficial, but not confirmed yet.The advising mechanisms for non-doing or withdraw long-term dialysis. All these studies will be performed in a multicentered project. Three medical centers in which CKD researches have been conducted for many years will provide a large cohort and share the data collected from their own hospitals. We expect that the results will provide an excellent guideline for CKD care, achieve cost-effectiveness of dialysis therapy and better life quality of ESRD patients.
|Study Design:||Observational Model: Case-Only
Time Perspective: Retrospective
|Official Title:||Prevention and Treatment of Chronic Kidney Disease in Taiwan - Development of Early Diagnostic Techniques and Setup of Local Therapeutic Guidelines and Standards|
|Study Start Date:||March 1998|
|Study Completion Date:||December 1998|
|Primary Completion Date:||March 1998 (Final data collection date for primary outcome measure)|
Purpose: Development of early diagnostic techniques and setup of local therapeutic guidelines and standards.
Design: The group plans to host the co-operation of hospitals, based on the geographical distribution of co-operation of several hospitals to choose the renal physician interviews the doctor and patient received a total of 30 objects was conducted qualitative in-depth interviews.
Inclusion criteria): To withdraw from dialysis treatment of chronic kidney disease, qualitative research, to-depth interviews, field observation, video recording, and public hospitals at the same time the collection of literature.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00912704
|Principal Investigator:||Chang Duan-Rong, doctor||the Institute of Health Care Organization Administration (IHCOA)|